UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 31, 2017
Accession Number:
Submission Type:
CIK: 0001421204
Company Name: Inspyr Therapeutics, Inc.
File Number: 333-215561